FinanceCity
HealthcareNSE · BSE

Aarti Pharmalabs Limited

AARTIPHARM · ISIN INE0LRU01027

Share price

₹641 +0.05%

Market capitalisation

₹5811 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹5811 Cr

Current price

₹641

+0.05% today

52W high

₹971

52W low

₹585

Stock P/E

33.35

P/B ratio

2.74

02 · Per share & returns

EPS (TTM)

₹19.22

Book value

₹234

ROE

8.49%

ROA

5.83%

Dividend yield

0.62%

Beta

0.23

03 · Financials (TTM)

By the numbers

Revenue

₹1819 Cr

+3.30% YoY

EBITDA

₹402 Cr

Net profit

₹175 Cr

-30.80% YoY

Profit margin

9.60%

Operating margin

17.50%

Total debt

₹794 Cr

Total cash

₹9.62 Cr

Debt / equity

0.37x

Current ratio

1.49x

Payout ratio

20.78%

04 · Analyst view

Target price

₹740

Upside

+15.45%

Consensus

NONE

Analysts

1

05 · Shareholding pattern

Who owns AARTIPHARM?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
AARTIPHARM
Exchange
NSE · BSE
CIN
ISIN
INE0LRU01027
BSE code
543748
Sector
Healthcare
Industry
Healthcare
Face value
₹5
Listing date
29 Jan 2023
Employees
Headquarters
Mumbai, India

07 · About

What is Aarti Pharmalabs Limited?

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Aarti Pharmalabs Limited?+

The Corporate Identity Number for Aarti Pharmalabs Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Aarti Pharmalabs Limited?+

Promoter and group-holding details for Aarti Pharmalabs Limited are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Aarti Pharmalabs Limited?+

Aarti Pharmalabs Limited (AARTIPHARM) has a market capitalisation of approximately ₹5811 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →